AnewHealth lands Linden, Nautic backing as patient base nears 160,000
What's the deal? AnewHealthDealroom has a profile for this one. Try Dealroom →, a national pharmacy provider for people with complex medical needs, has secured strategic growth investments from Linden CapitalDealroom has a profile for this one. Try Dealroom → Partners and existing investor Nautic PartnersDealroom has a profile for this one. Try Dealroom →. The two firms will jointly govern the company, with President and CEO Brian Adams and his management team staying in place. Financial terms were not disclosed.
Why now? The investment follows a stretch of growth: AnewHealth now serves more than 160,000 pharmacy patients nationwide, up nearly 50% over two years.
What's the endgame? For nearly two decades, AnewHealth has worked as a clinical pharmacy and medication management partner to value-based care organizations, including Programs of All-Inclusive Care for the Elderly (PACE). It reports an average 5% reduction in total cost of care. The new backing aims to accelerate growth and expand its reach.
Who's investing? Linden, which calls itself the largest dedicated healthcare private equity firm, has backed more than 50 companies since 2004, including pharmacy businesses such as ArtesRxDealroom has a profile for this one. Try Dealroom →, IVX Health, and Vital CareDealroom has a profile for this one. Try Dealroom →. Nautic first invested through ExactCare Pharmacy, and The Vistria Group remains an existing investor.
"AnewHealth has established a leading position at the intersection of pharmacy services, technology, and value-based care," said Brian Miller, co-founder and partner at Linden Capital Partners. Adams said the firms' combined resources leave the company "well positioned to accelerate our growth, expand our reach."
The signal: The deal fits 2026's selective healthcare market, which has favored businesses with recurring revenue and clear growth prospects even as reimbursement uncertainty weighs on diligence. Its notable feature is the pairing of two healthcare investors with pharmacy expertise — a vote for strategic backing over consolidation for scale alone.
Read more: business.theeveningleader.com
Image credit: Generated with Gemini
